The Future Of Nano Technology
- Alan Watts
- Anti-Aging Medicine
- David Sinclair
- Gene Medicine
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Hormone Replacement Therapy
- Human Genetic Engineering
- Human Reproduction
- Integrative Medicine
- Life Skills
- Longevity Medicine
- Medical School
- Nano Medicine
- Parkinson's disease
- Regenerative Medicine
- Stem Cell Therapy
- Stem Cells
- Missing Link To Longevity Discovered In The Plant Kingdom – Texas A&M University
- 2nd Annual Innovation Summit Focuses on Needs of Older Adults and Longevity Economy – PRNewswire
- Building the Body | News Center – UNLV NewsCenter
- University’s Seed Grant Initiative Helps Researchers’ Pursuits Blossom – University of Texas at Dallas
- Global Bio Decontamination Equipment Market, Forecast to 2026: Drivers, Restraints, Opportunities, Developments, Segments & Players -…
|Search Immortality Topics:|
Category Archives: BioEngineering
Laypeople may think of engineering as being more about numbers and materials than human beings. But thats not the case, especially with bioengineering. Its a field that synthesizes engineering techniques with the biological sciences. Electrical and computer engineering professor Pushkin Kachroo and his department have been committed to expanding bioengineerings reach since his arrival at UNLV more than 10 years ago. With the creation of the universitys School of Medicine, the opportunities for collaboration are growing.
Its a common-sense link that health, medicine and engineering, should be connected together, Kachroo said. Thats where health is going.
Thanks to the new Howe Fellowship in Bioengineering at UNLV, the work of two engineering graduate students is getting a boost in showcasing the ways engineering can materially benefit human health and well-being.
Lina Chato was always good at math growing up in her native Iraq, but she found her real passion when her school opened a new computer lab. Fellow students showed her some simple programs, let her borrow books, and before long she had written her first program about computer-aided learning for electrical circuit design. She was only 13 years old.
Chato received a bachelors degree in computer engineering and a masters degree in mechatronics engineering from the University of Technology, Baghdad. She joined the faculty and published three papers, but when the country became unstable due to the war, she fled with her family to the United States. She settled in Las Vegas, where two of her sisters already lived, and applied to UNLV's College of Engineering. Chato worked as a research assistant before beginning her doctorate program.
I came as a refugee, without any source of money, she said. This first opportunity was really appreciated and important to start my Ph.D. study.
Chato became interested in using machine learning to try to better analyze MRI images of brain tumors. Her work revolves around developing models to predict survival time for Glioma tumor patients. These types of tumors represent nearly three quarters of all malignant tumors.
We still dont know how these tumors behave, she said. The behavior of tumors is an important factor in predicting survival. This model can describe how a brain tumor develops. If we can know that, we can use this in the treatment stage.
When he graduated from the Las Vegas Academy of the Arts, Jadin Tredup wasnt sure what he wanted to do pursue music or study math. So he entered UNLVs then newly created entertainment engineering program.
It seemed like a pretty good blend of the two, Tredup said.
At UNLV his focus shifted away from music toward mechanical engineering, and then again toward electrical engineering. His journey took him from robotics to machine learning and artificial intelligence, to the problem of applying brain wave signals.
Now, having just finished his masters degree, hes working on a model to help patients he characterizes as having profound intellectual and multiple disabilities people with very severe and limited cognitive and motor functioning and an inability to communicate verbally.
The idea is, because our bodies carry so much more information beyond what we can produce in words, if we can sense all these physiological signals we can then translate them using AI and machine learning into a language and vocabulary for people, he said.
Tredups work leverages a theory about how the environment impacts how we communicate. For instance, EEGs can measure brain waves and translate them into emotional states; sensors can measure galvanic skin response (sweat, basically, an indicator of emotional state); and eye tracking can measure what patients are paying attention to. They can detect nearly instantaneous changes, allowing researchers to deduce, for example, that a barking dog might be causing anxiety. You can translate the data into a basic language, like Im feeling anxious because of the dog barking.
The next step is to develop a needs assessment for a few specific patients at a care facility, then further develop the algorithm.
No one model is easily applicable person-to-person, Tredup said. We have to create a generalizable model.
Tredup began his doctorate program at UNLV this fall. (He is the fourth in his family after his parents and brother to graduate from UNLV.) The Howe Foundation Fellowship will afford him more time to concentrate on research instead of juggling full-time research and a full-time job. Similarly, Chatos award will help her focus more energy on her research and spend less time as a teaching assistant.
Working with algorithms is cool, but it doesnt mean much unless it has applicability to the world around it, said Tredup. I can use everything Ive learned and help better peoples lives.
Read the rest here:
Building the Body | News Center - UNLV NewsCenter
Global Bio Decontamination Equipment Market, Forecast to 2026: Drivers, Restraints, Opportunities, Developments, Segments & Players -…
DUBLIN--(BUSINESS WIRE)--The "Global Bio Decontamination Equipment Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
The Global Bio-decontamination Equipment market is expected to reach $224.24 million by 2026 growing at a CAGR of 8.1% from 2018 to 2026.
Factors such as rise in use of these equipments in hospitals and other healthcare institutions and increasing number of government initiatives are driving the market growth. Though, the high expenses of the product, particularly powered and strict government regulations in some countries is projected to inhibit the growth of the market. Moreover, rising number of technological applications may provide ample opportunities for the market growth.
By application, pharmaceutical manufacturing segment acquired significant growth in the market owing to aging population and rising chronic and infectious diseases, the pharmaceutical producers are investing heavily in these equipments. Microbial testing and equipment decontamination can be offered as a value-added service to pharmaceutical manufacturers.
The key vendors mentioned are Bioquell, STERIS Life Science, TOMI Environmental Solutions, Fedegari Group, Howorth Air Technology, JCE Biotechnology, Weike Biological Laboratory, Tailin BioEngineering and Noxilizer.
Key Questions Answered in this Report
Key Topics Covered
1 Market Synopsis
2 Research Outline
3 Market Dynamics
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bio Decontamination Equipment Market, By Product Type
5.2 Type 1
5.3 Type 2
6 Global Bio Decontamination Equipment Market, By Type
6.2 Room Decontamination
6.3 Chamber Decontamination
6.4 Starch Blend with PLA
7 Global Bio Decontamination Equipment Market, By Product
7.3 Steam Sterilizers
7.4 Pure Steam & Water Systems
7.5 Washers & Dryers
7.6 VHP Sterilization & Biodecontamination
7.7 Transfer Airlocks
7.8 Vaprox Hydrogen Peroxide
8 Global Bio Decontamination Equipment Market, By Application
8.2 Bioscience Research
8.3 Pharmaceutical Manufacturing
8.4 Life Science Industry
8.5 Hospital & Healthcare
8.7 Vitro Fertilization (IVF)
8.8 Animal Care
9 Global Bio Decontamination Equipment Market, By Geography
9.2 North America
9.5 South America
9.6 Middle East & Africa
10 Strategic Benchmarking
11 Vendors Landscape
11.2 STERIS Life Science
11.3 TOMI Environmental Solutions
11.4 Fedegari Group
11.5 Howorth Air Technology
11.6 JCE Biotechnology
11.7 Weike Biological Laboratory
11.8 Tailin BioEngineering
For more information about this report visit https://www.researchandmarkets.com/r/1q2xof
University’s Seed Grant Initiative Helps Researchers’ Pursuits Blossom – University of Texas at Dallas
Text size: research
Grants Invest in Interdisciplinary Work That May Produce Bigger, Federally Funded Projects
Nov. 21, 2019
The first year of The University of Texas at Dallas seed grant initiative has provided $2.2 million to a diverse range of research and scholarly projects with the aim of providing faculty a springboard to earning larger, highly competitive grants.
The Office of Research program, announced last fall, was conceived by Dr. Joseph Pancrazio, vice president for research, who described it as among the largest such programs in the state.
Research, scholarship and creativity play a key role in our growth as an institution, said Pancrazio, who is also a professor of bioengineering in theErik Jonsson School of Engineering and Computer Science. These programs build upon the interdisciplinary work that is a hallmark of the UTDallas experience for our faculty and students. The hope is that this seed funding leads to new ideas that then become the source for new grant proposals and projects.
Distributions to UTDallas from the National Research University Fund (NRUF), a source of state research funding that the University first qualified for in 2018, freed up resources to create the seed grants.
By investing in our faculty while incentivizing collaboration, we are reinforcing a research culture that will encourage prospective investigators to join our academic community as well as earn a return-on-investment relative to federally sponsored research, Pancrazio said.
The seed grants fall into seven categories and will fund work in seven of the Universitys schools.
The program is overseen by Dr. Nicole Leeper Piquero, Robert E. Holmes Jr. Professor of Criminology, who said the program is an exciting way to invest in faculty and encourage interdisciplinary collaboration.
We offer 10 different ways to support researchers from all across our campus, including opportunities for them to showcase their work with workshops both here at UTDallas as well as in Washington, D.C., said Piquero, who is also associate vice president for research development.
Among the seven programs is the Collaborative Biomedical Research Award (CoBRA), which was specifically designed to stimulate interdisciplinary research between faculty at UTDallas and UTSouthwestern Medical Center. Three projects led by Dr. Danieli Rodrigues, associate professor of bioengineering; Dr. Lloyd Lumata, assistant professor of physics; and Dr. Lawrence Reitzer, professor of biological sciences, each received $250,000.
Lumatas grant supports research to develop biomedical imaging techniques, and Reitzers work focuses on combating urinary tract infections.
Rodrigues said the CoBRA award will enable her team to expand the application of an immune-interactive coating she is developing for titanium orthopedic implants that may reduce the implantation failure rate for diabetic patients.
This initiative will give us the opportunity to generate data that will support development and feasibility demonstrations, helping our team to pursue larger grant opportunities in the future, Rodrigues said. It will also promote interdisciplinary training by enabling UTD graduate students and residents from UTSouthwestern to work together on new ways to boost implant healing in immune-compromised cases.
Another program, called the Major Extramural Grant Award (MEGA), assists researchers who are gathering preliminary data to support their pursuit of individual external grant opportunities of at least $6 million. The two MEGA recipients, Dr. Roderick Heelis, director of the William B. Hanson Center for Space Sciences, and Dr. Bart Rypma, the Meadows Foundation Chair in Behavioral and Brain Sciences, each received $200,000 for their proposals.
The Office of Research invites potential applicants to Proposers Day on Friday, Nov. 22, to learn more about the internal funding opportunities available in the next cycle of seed grant initiatives. Registration is required.
Rypmais investigating brain-imaging techniques, while Heelis work aims to better understand Earths space environment and how it affects areas such as communication, navigation and the reentry of space vehicles. His MEGA project seeks to develop innovative techniques to measure the dynamics of particles and gases in the environment around orbiting satellites.
The experiments we do in space are really expensive. Sponsors like NASA and the Air Force wont give you all the money for a project just based on one proposal, said Heelis, Distinguished Chair in Natural Sciences and Mathematics.
Backing from the University allows us to turn our experiments and our conceptual ideas into real things: Heres the prototype device; here are the results from testing it in the lab, Heelis said. And we can put those forward in our second-phase grant proposal. This gives us a much more competitive chance of winning.
The Office of Research awarded seed grants in seven programs:
Media Contact: Stephen Fontenot, UT Dallas, (972) 883-4405,[emailprotected]or the Office of Media Relations, UT Dallas, (972) 883-2155, [emailprotected]
Read more from the original source:
University's Seed Grant Initiative Helps Researchers' Pursuits Blossom - University of Texas at Dallas
FSM eDigest | November 19. 2019
By By Cori Annapolen Goldberg and Sung W. Park
As food regulatory attorneys, we become somewhat excited when the U.S. Food and Drug Administration (FDA) or the U.S. Department of Agriculture (USDA) issues a new law or policy; we think about how it affects our clients and whether the new law or policy truly promotes the public good. What we often notice, however, is that implementation of such rule or policies often becomes delayed, or an extra grace period is provided for the companies to comply. For example, FDA recently announced that it will not require compliance with the new 2016 nutrition labeling rule until July 1, 2020 for certain companies. Similarly, USDA is also providing a buffer period for enforcement for the bioengineering disclosure rule until January 1, 2022, although the official effective date of the rule is January 1, 2020. Such enforcement discretion or buffer periods can be helpful in ensuring that the changes in laws do not affect business negatively. We have been receiving many questions about these laws and regulations recently. Although the agencies may delay enforcement again, we wanted to take this opportunity (and the extra time) to address a few questions regarding the new upcoming FDA and USDA labeling regulations.
First, the question that we probably receive the most often is: which party is ultimately responsible for ensuring compliance with the new regulations? The modern food supply chain is complex. The majority of food and food ingredients are imported from overseas, sometimes processed in the United States (oftentimes by contract manufacturers), at times repackaged by third-party distributors, and only then finally marketed to the public. This complex supply chain means that deciding who is responsible for regulatory compliance can be difficult because so many parties are involved in the process. The short answer to this question is that theoretically, any party that is responsible for introducing the food into interstate commerce is responsible for correct labeling. This is because federal law prohibits sales, marketing, or distribution of any products that violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations.
In practice, however, FDA is likely to consider certain parties to be more responsible for compliance than others. In fact, FDA mentions some of these examples in its guidance. For example, FDA may consider a private label distributor to be more responsible than the contract manufacturer for labeling compliance because the private label distributor is directly responsible for introducing the product to consumers. On the other hand, FDA states that the supplier of a food ingredient is responsible for the accuracy of the information it provides to the processor if there is no suitable way for the processor to determine nutrient values; this is because here, the supplier is the one that can ensure compliance. While the answer to the question of who is responsible will differ in every case, a good way of solving this issue in advance is to delineate in the contract the regulatory obligations of each party (e.g., label review before the final release of the product). This will help ensure regulatory compliance and in the unfortunate event that any noncompliance is found, the parties will able to resolve the disputes more effectively, hopefully without resorting to costly and lengthy dispute resolution mechanisms.
In addition, we often hear about what exact changes were made to the nutrition labeling rule. FDA made several key changes to nutrition labeling. Importantly, FDA instituted a new requirement for Added Sugarssugars that are added during processing of the food. This is applicable to many types of sugars, including syrups and honey, certain concentrated fruit or vegetable juices, and free-, mono-, or disaccharide forms of sugars (for general changes to the format, please refer to the graphic below graphic from FDA; on the left is the old panel, and on the right is the new panel). Importantly, what many industry members overlook is that the new rule includes record-keeping requirements. For example, records must be kept for 2 years to support the declaration of dietary fiber in the product. Similarly, manufacturers must keep a record of the amount of added sugars in foods that may go through nonenzymatic browning or fermentation, because it may not be technologically possible to distinguish between naturally occurring sugars and added sugars in such circumstances. This may be a particularly important change both from regulatory and consumer litigation perspectives, given that plaintiffs attorneys regularly scrutinize the food labels for any potential sources of lawsuits.
Lastly, although not an FDA requirement, while were on the subject of labeling changes, we would like to note that a new USDA bioengineering labeling requirement will become effective on January 1, 2020, although the agency will not enforce until January 1, 2022. While this might seem far away, the bioengineering disclosure rule may require changes to the product formulations or the supply chain. In short, the USDAs bioengineering labeling rule requires disclosure on whether a product contains detectable genetic materials that have been modified in labs and not found in the nature (i.e., genetic engineering). While certain exemptions exist (e.g., foods subject to the USDA labeling jurisdiction with the predominant ingredient also regulated by the USDA; incidental additives), generally speaking, food containing genetically engineered ingredients will need to disclose such inclusion through graphic or textual messages (e.g., bioengineered food, contains a bioengineered food ingredient, or a symbol). Interestingly, the USDA stated that although the implementation date is January 1, 2020, the agency will begin enforcement on January 1, 2022. While some time remains, companies will want to review this quickly to determine the proper marketing and regulatory strategy given that this may result in formulation changes.
In sum, there is likely to be a sea change in the regulatory environment for food manufacturers, distributors, and marketers because of the new FDA labeling regulations and USDA disclosure rules coming into effect beginning in 2020 through 2022. We understand first-hand from working with our clients how much time, money, and effort it can take to update the labels. While such changes may be challenging at first, manufacturers, distributors, or marketers that embrace and prepare for the changes in advance will be able to minimize the risk of regulatory enforcement and focus their energy on building their business. We would like to invite you to review these rules closely, and begin the preparation. If you have any questions, please do not hesitate to reach out to us.
Cori Annapolen Goldberg, a partner in the ReedSmith Life Sciences Health Industry Group, focuses her practice on FDA regulatory issues for the food, drug, medical device and cosmetic industries across the supply chain, including companies investing in these industries.Sung W. Park is an associate in the Life Sciences Health Industry Group in the Washington D.C. office. His practice focuses on providing regulatory counsel to companies developing, distributing, and marketing FDA-regulated products, and responding to regulatory and administrative enforcement actions by federal and state agencies such as FDA, USDA, and state Attorneys General offices.
References1. http://www.fda.gov/food/food-labeling-nutrition/industry-resources-changes-nutrition-facts-label#Compliance .2. The Federal Food, Drug and Cosmetic Act. 21 U.S.C. 301(a).3. FDA Guidance to the Industry, Nutrition and Supplement Facts Labels: Questions and Answers Related to the Compliance Date, Added Sugars, and Declaration of Quantitative Amounts of Vitamins and Minerals: Guidance for Industry (November 2018).4. For certain small food manufacturers, the effective date is January 1, 2021.
Blood clots have long been implicated in heart attacks and strokes, together accounting for almost half of deaths annually in the United States. While the role of one key protein in the process, called von Willebrand factor, has been established, a reliable model for predicting how vWF collects in blood vessels remains elusive.
Researchers at the Georgia Institute of Technology published a review of recent work on understanding the behavior of vWF in APL Bioengineering, from AIP Publishing. The paper paints a portrait of vWF, which uncoils under the shear stress of blood flow to form nets that trap platelets passing by, which then form a blood clot, called a thrombus. By highlighting advances in the field, the authors put forth promising avenues for therapies in controlling these proteins.
The thrombus must block blood flow as it closes off, like trying to use your thumb at the end of a garden hose and then stopping all flow with some mud. This is extremely hard to accomplish, so thrombosis requires the fastest, strongest bonds in all of biology."
David Ku, an author on the paper
One challenge is that many of today's experimental models can only image events on the scale of microns every second or so. vWF proteins, however, are approximately one-thousandth of that size, and their interactions occur in one-thousandth of that time.
A variety of computer models have been proposed to bridge the gap from microscale to nanoscale in clot formation, ranging from simulations based on the time it takes for clots to form to computationally intensive models that re-create how platelets, vWF and cells all interact in the bloodstream. The paper calls on researchers across biology, computer science and other areas to collaborate to build an improved model.
In addition to targeting platelet aggregation and high-shear environments that stretch vWF, one potential therapy is to enhance the activity of another protein, ADAMTS13, which cleaves vWF and renders it unable to form clots. While research in mouse models shows promise, much work is still required to determine if ADAMTS13 therapies would be safe or effective for humans.
Ku's own research pointed to negatively charged nanoparticles that computational modeling has shown might keep vWF in its coiled unreactive state. The group found the nanoparticles reduce how quickly vessels become occluded and are exploring how to explain and optimize this process.
Ku said he hopes the paper will inspire others to dive deeper into new ways of measuring and understanding the clot-forming vWF.
Kim, D., et al. (2019) Occlusive thrombosis in arteries. APL Bioengineering. doi.org/10.1063/1.5115554.
See the original post here:
Researchers lay foundation for reliable blood clotting molecule models - News-Medical.net
3D Printing in Medical Applications Market to Make Great Impact in Near Future by 2025 – Tech Admirers
A new business intelligence report released by HTF MI with title Global 3D Printing in Medical Applications Market Professional Survey Report 2019 is designed covering micro level of analysis by manufacturers and key business segments. TheGlobal 3D Printing in Medical Applications Market survey analysisoffers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys.
Whats keeping 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by HTF MIGet Free Sample Report + All Related Graphs & Charts @:https://www.htfmarketreport.com/sample-report/2210310-global-3d-printing-in-medical-applications-market-4
Market Overview of Global 3D Printing in Medical ApplicationsIf you are involved in the Global 3D Printing in Medical Applications industry or aim to be, then this study will provide you inclusive point of view. Its vital you keep your market knowledge up to date segmented by Applications [Medical Implants, Bioengineering Products, Surgical Guides & Surgical Instruments], Product Types [, Polymers, Ceramics, Metals, Biological Cells, Electron Beam Melting, Laser Beam Melting, Photo Polymerization & Droplet Deposition Manufacturing] and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.
This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market.
Furthermore, the years considered for the study are as follows:Historical year 2013-2018Base year 2018Forecast period** 2019 to 2025 [** unless otherwise stated]
**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.
The titled segments and sub-section of the market are illuminated below:The Study Explore the Product Types of 3D Printing in Medical Applications Market: , Polymers, Ceramics, Metals, Biological Cells, Electron Beam Melting, Laser Beam Melting, Photo Polymerization & Droplet Deposition Manufacturing
Key Applications/end-users of Global 3D Printing in Medical Applications Market: Medical Implants , Bioengineering Products, Surgical Guides & Surgical Instruments
Top Players in the Market are: 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys
Region Included are: North America, Europe, China, Japan, Southeast Asia & India
Enquire for customization in Report @:https://www.htfmarketreport.com/enquiry-before-buy/2210310-global-3d-printing-in-medical-applications-market-4
Important Features that are under offering & key highlights of the report: Detailed overview of 3D Printing in Medical Applications market Changing market dynamics of the industry In-depth market segmentation by Type, Application etc Historical, current and projected market size in terms of volume and value Recent industry trends and developments Competitive landscape of 3D Printing in Medical Applications market Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards 3D Printing in Medical Applications market performance Market players information to sustain and enhance their footprint
Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/2210310-global-3d-printing-in-medical-applications-market-4
Major Highlights of TOC:Chapter One: Global 3D Printing in Medical Applications Market Industry Overview1.1 3D Printing in Medical Applications Industry1.1.1 Overview1.1.2 Products of Major Companies1.2 3D Printing in Medical Applications Market Segment1.2.1 Industry Chain1.2.2 Consumer Distribution1.3 Price & Cost Overview
Chapter Two: Global 3D Printing in Medical Applications Market Demand2.1 Segment Overview2.1.1 APPLICATION 12.1.2 APPLICATION 22.1.3 Other2.2 Global 3D Printing in Medical Applications Market Size by Demand2.3 Global 3D Printing in Medical Applications Market Forecast by Demand
Chapter Three: Global 3D Printing in Medical Applications Market by Type3.1 By Type3.1.1 TYPE 13.1.2 TYPE 23.2 3D Printing in Medical Applications Market Size by Type3.3 3D Printing in Medical Applications Market Forecast by Type
Chapter Four: Major Region of 3D Printing in Medical Applications Market4.1 Global 3D Printing in Medical Applications Sales4.2 Global 3D Printing in Medical Applications Revenue & market share
Chapter Five: Major Companies List
Chapter Six: Conclusion
Buy the Latest Detailed Report @https://www.htfmarketreport.com/buy-now?format=1&report=2210310
Key questions answered Who are the Leading key players and what are their Key Business plans in the Global 3D Printing in Medical Applications market? What are the key concerns of the five forces analysis of the Global 3D Printing in Medical Applications market? What are different prospects and threats faced by the dealers in the Global 3D Printing in Medical Applications market? What are the strengths and weaknesses of the key vendors?
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Author:HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.
Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]
Connect with us atLinkedIn|Facebook|Twitter